Clinical Trial Keywords
head and neck squamous cell cancer; Oropharynx HPV positive cancers
Selected Publications
Marur, S.; Forastiere, A.A. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2008 Apr;83(4):489-501.
Marur, S.; Rudin, C.M. Genetic alterations in head and neck squamous cell carcinogenesis. In: Rose, B.D., editor, UpToDate: Oncology. Wellesley, MA: UpToDate; 2008.
Marur, S.; Rudin, C.M. Chemoprevention in oral dysplasia. In: Rose, B.D., editor, UpToDate: Oncology. Wellesley, MA: UpToDate; 2008.
Forastiere, A.A.; Marur, S. Head and Neck Cancer. In: Moore, A., editor. 4th Edition ed, ASCO Medical Oncology Self-Evaluation Program. Alexandria, VA: American Society of Clinical Oncology; 2009.
Higgins, M.J.; Forastiere, A.; Marur, S. New directions in the systemic treatment of metastatic thyroid cancer. Oncology. 2009;23(9):768-775.
Forastiere, A.A.; Marur, S. Head and Neck Cancer. Second Edition ed, ASCO-Sep: Medical Oncology Self-Evaluation Program; 2010.
Marur, S.; D''Souza, G.; Westra, W.H.; Forastiere, A.A. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010 Aug;11(8):781-789.
Marur, S.; Forastiere, A.A. Challenges of integrating chemotherapy and targeted therapy with radiation in locally advanced head and neck squamous cell cancer. Curr Opin Oncol. 2010 May;22(3):206-211.
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
Comments